• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Illegal Marketing Commissions Arrangements Cost Toxicology Lab $5.9 Million

Illegal Marketing Commissions Arrangements Cost Toxicology Lab $5.9 Million

by Glenn S. Demby | Apr 18, 2023 | News, Open Content

Recent case shows that toxicology labs and drug testing remain a primary target for federal enforcement agencies.

How to Explain the Current State of EKRA to Your Lab Executives

How to Explain the Current State of EKRA to Your Lab Executives

by Glenn S. Demby | Feb 24, 2023 | Brief Your CEO-lca, Essential, Lab Compliance Advisor, Reimbursement-lca

How to explain the current state of EKRA to your lab executives.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

Lab Sales & Marketing Compliance: The Current State of EKRA

by Glenn S. Demby | Feb 9, 2023 | Enforcement-nir, Essential, National Lab Reporter

Sales and marketing operations liability risks and the measures labs should and shouldn’t take to manage those risks.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Clinical Laboratory Enforcement Update

Clinical Laboratory Enforcement Update

by G2 Intelligence Staff | Jan 23, 2023 | Webinars, webinars free

Get an overview of trending areas of enforcement and steps labs and pathology practices can consider to protect their businesses.

Court Refuses to Dismiss EKRA Charges against Former Arrayit CEO

Court Refuses to Dismiss EKRA Charges against Former Arrayit CEO

by Glenn S. Demby | Jun 22, 2022 | Essential, Lab Compliance Advisor, Labs in Court-lca

In this month’s Labs in Court roundup, Arrayit’s former president loses his bid to have EKRA charges dismissed, and more.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Log In

Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2026 G2Intelligence.com